| Name | Title | Contact Details |
|---|
Kavak is a global company with operations in Mexico, Argentina, Brazil, Chile, Turkey, Saudi Arabia, Oman and United Arab Emirates. We are the number one e-commerce company in the purchase and sale of pre-owned vehicles and the most highly valued private startup in Latin America. Kavak is also the first Unicorn Company in the history of Mexico, with a current valuation of US$8.7 billion. We have thousands of kavak@s from more than 40 different nationalities and growing. As part of this accelerated growth, we want to make sure we surround ourselves with the best talent to help us continue to build the technology, processes and products that will allow us to transform the automotive market around the world. Our team is the number one priority. We like to imagine the impossible and work together to achieve it. We are disruptive, proactive, loyal and ambitious. Interested in joining? Apply now.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Adams Brown is a regional certified public accounting and advisory firm based in Wichita, Kansas, founded in 1945. With nearly 400 professionals, the firm serves clients across all 50 U.S. states, Canada, and the Caribbean. It is recognized as one of the largest accounting firms in Wichita and is affiliated with BKR International, which enhances its ability to assist clients with international business operations. The firm offers a wide range of services, including tax planning and compliance, audit and assurance, business consulting, client accounting and advisory services, wealth management, and managed IT and cybersecurity services. Adams Brown has specialized teams focused on various industries, such as agriculture, construction, manufacturing, healthcare, and not-for-profit organizations. The firm emphasizes a client-centric approach, fostering strong relationships and providing personalized service to closely held and family-owned businesses, as well as individuals and families seeking financial planning.
Health In Tech is an insurtech company focused on enhancing the self-funding process in the healthcare sector. The company aims to create efficient and innovative solutions that benefit individuals and businesses while improving the health insurance landscape. It operates a dynamic marketplace that utilizes third-party AI technology to deliver customized solutions. The company offers a variety of proprietary digital platforms and services that streamline the quoting and underwriting processes for brokers, third-party administrators, and insurers. Key offerings include reference-based pricing, group insurance captives, community health plans, and the eDIYBS platform for small and medium-sized employers. Additionally, the Health Intelligence Card and HI Performance Network are designed to improve the management of medical records and claims while providing cost-effective healthcare options. Health In Tech, Inc. is publicly traded on NASDAQ under the ticker symbol HIT and was founded in 2014. The company is led by CEO Tim Johnson and has around 80 employees.